You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Orexin Antagonish

Showing 1 - 25 of 38
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Nicotine Dependence Trial in Baltimore (Placebo, Belsomra)

Not yet recruiting
  • Nicotine Dependence
  • Baltimore, Maryland
    National Institute on Drug Abuse
Feb 2, 2023

Alzheimer, Insomnia Disorder, Sleep Trial in Montpellier (drug, procedure, behavioral, other)

Not yet recruiting
  • Alzheimer Disease
  • +2 more
  • Daridorexant 50 mg
  • +7 more
  • Montpellier, France
    University Hospital, Montpellier
Jun 20, 2023

Insomnia, Dementia, Frontotemporal Dementia Trial (Lemborexant 5 MG)

Not yet recruiting
  • Insomnia
  • +2 more
  • Lemborexant 5 MG
  • (no location specified)
Oct 16, 2023

Insomnia, Anesthesia Trial in Mugla (Jenkins Sleep Disorders scale and Epworth Sleepiness scale)

Not yet recruiting
  • Insomnia
  • Anesthesia
  • Jenkins Sleep Disorders scale and Epworth Sleepiness scale
  • Mugla, Turkey
    Mugla Sitki Kocman University
Dec 16, 2022

Tobacco Use Disorder Trial in Shenzhen (extinction training (nicotine cues), extinction training (neutral cues), Time-restricted

Not yet recruiting
  • Tobacco Use Disorder
  • extinction training (nicotine cues)
  • +4 more
  • Shenzhen, Guangdong, China
    Shenzhen Kangning Hospital
Jul 14, 2023

Cocaine Use Disorder Trial in Lexington (Suvorexant, Cocaine, Placebo oral capsule)

Completed
  • Cocaine Use Disorder
  • Lexington, Kentucky
    University of Kentucky
Dec 7, 2022

Shift-Work Related Sleep Disturbance Trial in San Francisco (Lemborexant, Placebo)

Recruiting
  • Shift-Work Related Sleep Disturbance
  • San Francisco, California
    University of California, San Francisco
Apr 19, 2022

Sleep Initiation and Maintenance Disorders, Stress Disorders, Posttraumatic Trial in San Francisco, Salisbury (Suvorexant,

Recruiting
  • Sleep Initiation and Maintenance Disorders
  • Stress Disorders, Posttraumatic
  • San Francisco, California
  • +1 more
Nov 10, 2022

Narcolepsy, Idiopathic Hypersomnia, Cataplexy Trial (Quantitative mass spectrometry assay)

Not yet recruiting
  • Narcolepsy
  • +2 more
  • Quantitative mass spectrometry assay
  • (no location specified)
Nov 7, 2022

Autism, Autism Spectrum Disorder Trial (Suvorexant, Placebo)

Not yet recruiting
  • Autism
  • Autism Spectrum Disorder
  • (no location specified)
Dec 20, 2022

Chronic Insomnia and CSF Markers of Dementia

Recruiting
  • Insomnia Chronic
  • lumbar puncture
  • Philadelphia, Pennsylvania
    University of Pennsylvania
Feb 2, 2023

Nicotine Dependence Trial in Belmont (Suvorexant 20 mg, Suvorexant 10 mg, Placebo oral tablet)

Recruiting
  • Nicotine Dependence
  • Suvorexant 20 mg
  • +2 more
  • Belmont, Massachusetts
    McLean Hospital
Aug 30, 2021

Alcohol Use Disorder Trial in Columbus (Suvorexant, Placebo)

Recruiting
  • Alcohol Use Disorder
  • Columbus, Ohio
    The Ohio State University
Dec 11, 2022

Hyperemesis Gravidarum, Pregnancy Related Trial in Siirt (Blood sample)

Completed
  • Hyperemesis Gravidarum
  • Pregnancy Related
  • Blood sample
  • Siirt, Turkey
    Siirt Üniversity Medical Faculty
Jan 31, 2023

Anesthesia Trial in Yinchuan (Dexmedetomidine, Saline)

Completed
  • Anesthesia
  • Yinchuan, Ningxia, China
    Anesthesiology department of General Hospital of Ningxia Medical
Jun 18, 2021

PTSD Trial in Washington (suvorexant, )

Completed
  • Posttraumatic Stress Disorder
  • Washington, District of Columbia
    Clinical Research Unit; Howard University Hospital
May 26, 2021

Opioid Dependence, Opioid Withdrawal, Sleep Disturbance Trial in Baltimore (Placebo oral capsule, Low Dose Suvorexant, High Dose

Completed
Has Results
  • Opioid Dependence
  • +2 more
  • Placebo oral capsule
  • +2 more
  • Baltimore, Maryland
    Johns Hopkins Bayview Medical Center
Jul 12, 2022

Panic Disorder Trial in Fresno (suvorexant, )

Completed
Has Results
  • Panic Disorder
  • Fresno, California
    UCSF Fresno Medical Education Program
Jun 4, 2021

Sleep Disturbance, Opioid-use Disorder Trial in Baltimore, Bel Air, Elkton (Suvorexant, Placebos)

Recruiting
  • Sleep Disturbance
  • Opioid-use Disorder
  • Baltimore, Maryland
  • +4 more
May 16, 2022

Orexin-A, HLA Gene, PSG and MSLT in the Evaluation of Narcolepsy

Enrolling by invitation
  • Narcolepsy
    • Jinan, Shandong, China
      The First Affiliated Hospital of Shandong First Medical Universi
    Jun 23, 2021

    Opioid-use Disorder, Sleep Trial in Detroit (Suvorexant, Suvorexant Placebo)

    Recruiting
    • Opioid-use Disorder
    • Sleep
    • Detroit, Michigan
      Wayne State University
    Sep 8, 2021

    Insomnia, Alcohol Use Disorder Trial in Melbourne (Suvorexant 20 mg, )

    Recruiting
    • Insomnia
    • Alcohol Use Disorder
    • Suvorexant 20 mg
    • placebo
    • Melbourne, Victoria, Australia
      St Vincent's Hospital
    Aug 16, 2021

    Obstructive Sleep Apnea Syndrome With Residual Excessive Daytime

    Recruiting
    • Sleep Apnea Syndromes
    • Treatment
    • Oggebbio, Italy
      Istituto Auxologico Italiano
    Mar 21, 2023

    Elderly, Alzheimer Trial in New York (Actigraphy, Nocturnal Polysomnograpahy (NPSG))

    Completed
    • Elderly
    • Alzheimer Disease
    • Actigraphy
    • Nocturnal Polysomnograpahy (NPSG)
    • New York, New York
      New York University School of Medicine
    Feb 23, 2021

    Somnolence Disorder, Excessive Trial in Montpellier (scale of severity, blood sample)

    Recruiting
    • Somnolence Disorder, Excessive
    • scale of severity
    • blood sample
    • Montpellier, France
      UH Montpellier
    Nov 27, 2020